- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
54
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
54 companies
Caris Life Sciences
Market Cap: US$7.1b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$24.77
7D
-15.2%
1Y
n/a
BioLife Solutions
Market Cap: US$1.3b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$25.92
7D
-6.0%
1Y
7.5%
Daiichi Sankyo Company
Market Cap: JP¥6.4t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥3,465.00
7D
2.8%
1Y
-25.1%
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥28.3b
A biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of cancer and immunological diseases.
688192
CN¥61.66
7D
-2.7%
1Y
33.5%
Rhythm Pharmaceuticals
Market Cap: US$6.7b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$97.92
7D
-1.6%
1Y
63.0%
AbbVie
Market Cap: US$398.0b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$233.23
7D
7.6%
1Y
36.9%
Bonesupport Holding
Market Cap: SEK 13.9b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 211.60
7D
6.4%
1Y
-39.3%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥12.3b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥17.71
7D
3.2%
1Y
3.0%
Protagonist Therapeutics
Market Cap: US$5.3b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$84.85
7D
8.9%
1Y
98.9%
Immutep
Market Cap: AU$397.4m
A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.27
7D
1.9%
1Y
-12.9%
NewAmsterdam Pharma
Market Cap: US$4.5b
A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.
NAMS
US$38.27
7D
0.4%
1Y
55.5%
Hypera
Market Cap: R$16.3b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$25.74
7D
2.8%
1Y
24.5%
Cynata Therapeutics
Market Cap: AU$59.4m
Engages in the development and commercialization of proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.
CYP
AU$0.25
7D
6.4%
1Y
4.2%
Telix Pharmaceuticals
Market Cap: AU$5.1b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$14.93
7D
-4.0%
1Y
-35.0%
Neurocrine Biosciences
Market Cap: US$14.7b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$146.85
7D
-4.5%
1Y
17.0%
Akeso
Market Cap: HK$108.4b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$117.70
7D
3.2%
1Y
74.2%
Exact Sciences
Market Cap: US$12.8b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$68.37
7D
-1.8%
1Y
34.8%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€59.15
7D
2.6%
1Y
-9.6%
Avadel Pharmaceuticals
Market Cap: US$1.8b
Operates as a biopharmaceutical company in the United States.
AVDL
US$19.15
7D
1.0%
1Y
59.3%
Porton Pharma Solutions
Market Cap: CN¥13.2b
Provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial.
300363
CN¥24.42
7D
-2.2%
1Y
21.2%
Consun Pharmaceutical Group
Market Cap: HK$12.7b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.05
7D
0.3%
1Y
74.8%
Camurus
Market Cap: SEK 36.4b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 611.00
7D
3.8%
1Y
0.2%
BioGaia
Market Cap: SEK 10.5b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 103.30
7D
5.6%
1Y
-2.4%
Sandoz Group
Market Cap: CHF 23.8b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 55.24
7D
1.7%
1Y
36.9%
Shanghai Runda Medical Technology
Market Cap: CN¥9.5b
Shanghai Runda Medical Technology Co., Ltd.
603108
CN¥15.73
7D
-5.7%
1Y
-28.5%
AstraZeneca
Market Cap: UK£209.6b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£135.18
7D
8.6%
1Y
33.3%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$100.9b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$432.60
7D
-0.4%
1Y
158.9%
Sotera Health
Market Cap: US$4.6b
Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$16.25
7D
2.8%
1Y
6.1%
InnoCare Pharma
Market Cap: HK$28.2b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$14.58
7D
3.4%
1Y
107.1%
Hanall Biopharma
Market Cap: ₩2.1t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩40,700.00
7D
-8.3%
1Y
0.6%
Galderma Group
Market Cap: CHF 36.3b
Operates as a dermatology company worldwide.
GALD
CHF 153.00
7D
4.5%
1Y
80.5%
Vitrolife
Market Cap: SEK 19.6b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 144.60
7D
3.2%
1Y
-36.9%
Ligand Pharmaceuticals
Market Cap: US$4.1b
A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
LGND
US$205.61
7D
8.0%
1Y
68.4%
SK Biopharmaceuticals
Market Cap: ₩10.0t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩127,800.00
7D
6.0%
1Y
22.8%
Aroa Biosurgery
Market Cap: AU$265.7m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.77
7D
-1.9%
1Y
18.5%
Simcere Pharmaceutical Group
Market Cap: HK$33.8b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$13.04
7D
1.1%
1Y
109.6%